Petros Christopoulos

Papers authored by Petros Christopoulos

This paper was not found in any repository, but could be made available legally by the author.

2021 Miriam Blasi, Daniel Kazdal, Michael Thomas, Petros Christopoulos

, Mark Kriegsmann, Regine Brandt, Anna-Lena Volckmar

, Martina Kirchner, Claus Peter Heußel, Albrecht Stenzinger, Jonas Kuon

Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Jingjing Li, Bin Zhang, Yu Zhang, Feng Xu, Zhenfa Zhang, Lin Shao, Chunhe Yan, Paola Ulivi, Marc G. Denis, Petros Christopoulos

, Vincent Thomas de Montpréville, Eric H. Bernicker, Anthonie J. van der Wekken, Changli Wang, Dongsheng Yue

Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib

Upload

Anna-Lena Volckmar

, Eugen Rempel

, Huriye Seker-Cin, Hauke Winter, Peter Schirmacher, Michael Thomas

, Roland Penzel, Petros Christopoulos

, Albrecht Stenzinger, Martina Kirchner, Michael Allgäuer, Jan Budczies, Peter Horak

, Julia Glade

, Hannah Goldschmid and 13 other authors

Targeting rare and non-canonical driver variants in NSCLC – an uncharted clinical field

Upload

This paper is made freely available by the publisher.

Mei Elsayed, Petros Christopoulos

Therapeutic Sequencing in ALK+ NSCLC

Download from doi.org

Nikolaj Frost

, Petros Christopoulos

, Diego Kauffmann-Guerrero, Jan Stratmann, Richard Riedel, Monica Schaefer, Jürgen Alt, Sylvia Gütz, Daniel C. Christoph, Eckart Laack, Martin Faehling, Richard Fischer, Klaus Fenchel, Sebastian Haen, Lukas Heukamp and 2 other authors

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program

Download from doi.org

Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus-Peter Heußel, Felix J. Herth, Hauke Winter, Michael Meister, Thomas Muley, Stefan Fröhling, Solange Peters, Barbara Seliger

and 4 other authors

A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma

Upload

Nikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar

, Daniel Kazdal, Martina Kirchner, Felix J. Herth, Claus-Peter Heussel, Florian Eichhorn, Michael Meister, Thomas Muley, Rami A. Elshafie, Jürgen R. Fischer, Martin Faehling, Mark Kriegsmann, Peter Schirmacher and 4 other authors

Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer

Download from doi.org

2020 Tanja Eichkorn, Farastuk Bozorgmehr, Sebastian Regnery, Lisa A. Dinges, Andreas Kudak, Nina Bougatf, Dorothea Weber, Petros Christopoulos

, Thomas Muley, Sonja Kobinger, Laila König, Juliane Hörner-Rieber, Sebastian Adeberg, Claus Peter Heussel, Michael Thomas and 2 other authors

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates

Download from doi.org

Martin Faehling, Christian Schumann, Petros Christopoulos

, Petra Hoffknecht, Jürgen Alt, Marlitt Horn, Stephan Eisenmann, Anke Schlenska-Lange, Philipp Schütt, Felix Steger, Wolfgang M. Brückl, Daniel C. Christoph

Durvalumab after definitive Chemoradiotherapy in locally advanced NSCLC: Data of the German EAP

Download from doi.org

Steffen Dietz, Petros Christopoulos

, Zhao Yuan, Arlou Kristina Angeles

, Lisa Gu, Anna-Lena Volckmar, Simon J. Ogrodnik, Florian Janke, Chiara Dalle Fratte, Chiara Dalle Fratte, Tomasz Zemojtel, Marc A. Schneider, Daniel Kazdal, Volker Endris, Michael Meister and 7 other authors

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA

Download from doi.org

Nicolas Hohmann, Farastuk Bozorgmehr, Petros Christopoulos

, Gerd Mikus, Antje Blank, Jürgen Burhenne, Michael Thomas, Walter E. Haefeli

Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat

Download from doi.org

Maike de Wit, Eyck von der Heyde, Ulla von Verschuer, Matthias Zaiss, Matthias Zeth, Frank Griesinger, Juliana Ababei, Jürgen Alt, Andreas Ammon, Wilfried Eberhardt, Jürgen Anhuf, Ivo Azeh, Stefan Bauer, Dirk Behringer, Arnd Nusch and 148 other authors

Biomarker testing in non-small cell lung cancer in routine care: analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Upload

Katharina Kriegsmann, Moritz von Winterfeld, Christiane Zgorzelski, Thomas Muley, Petros Christopoulos

, Moritz Winterfeld, Esther Herpel, Benjamin Goeppert

, Gunhild Mechtersheimer, Peter Sinn

, Albrecht Stenzinger

, Peter Schirmacher, Hauke Winter, Monika Eichinger, Arne Warth and 1 other authors

Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA‐binding protein 3 in non‐small‐cell lung cancer

Upload

Martin Faehling, Christian Schumann, Petros Christopoulos

, Petra Hoffknecht, Jürgen Alt, Marlitt Horn, Stephan Eisenmann, Anke Schlenska-Lange, Philipp Schütt, Felix Steger, Wolfgang M. Brückl, Daniel C. Christoph

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable Non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)

Upload

Mark Kriegsmann

, Christiane Zgorzelski, Rita Casadonte

, Kristina Schwamborn, Thomas Muley

, Hauke Winter, Martin Eichhorn, Florian Eichhorn, Arne Warth, Soeren-Oliver Deininger, Petros Christopoulos

, Michael Thomas, Thomas Longerich, Albrecht Stenzinger, Wilko Weichert and 4 other authors

Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes

Download from doi.org

Lena Gaissmaier, Mariam Elshiaty, Petros Christopoulos

Breaking Bottlenecks for the TCR Therapy of Cancer

Download from doi.org

Farastuk Bozorgmehr

, Inn Chung, Petros Christopoulos

, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas, Stefan Rieken

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

Download from doi.org

Sabine Wessels, Thomas Muley, Petros Christopoulos

, Michael Meister, Ingrid Heinzmann-Groth, Arne Warth, Esther Herpel, Simone Hummler, Ursula Klingmüller, Jonas Kuon, Claus-Peter Heussel, Ralf Eberhardt, Felix J. F. Herth, Hauke Winter, Helge Bischoff and 5 other authors

Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives

Upload

P. Christopoulos

, M. Kirchner

, J. Roeper, F. Saalfeld, M. Janning

, F. Bozorgmehr

, N. Magios, D. Kazdal, A. L. Volckmar, L. M. Brückner, T. Bochtler, M. Kriegsmann, V. Endris, R. Penzel, K. Kriegsmann and 18 other authors

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Upload

Nir Peled, Roni Gillis, Saadettin Kilickap, Patrizia Froesch, Sergei Orlov, Elena Filippova, Umut Demirci, Petros Christopoulos

, Irfan Cicin, Fatma Bugdayci Basal, Cengiz Yilmaz, Moiseenko Fedor, Taner Korkmaz, Semra Paydas, Oliver Gautschi and 33 other authors

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Petros Christopoulos